| The productivity crisis in pharmaceutical R&D F Pammolli, L Magazzini, M Riccaboni Nature reviews Drug discovery 10 (6), 428-438, 2011 | 1199 | 2011 |
| Inventors and invention processes in Europe: Results from the PatVal-EU survey P Giuri, M Mariani, S Brusoni, G Crespi, D Francoz, A Gambardella, ... Research policy 36 (8), 1107-1127, 2007 | 610 | 2007 |
| A breath of fresh air? Firm type, scale, scope, and selection effects in drug development A Arora, A Gambardella, L Magazzini, F Pammolli Management Science 55 (10), 1638-1653, 2009 | 168 | 2009 |
| The sustainability of European health care systems: beyond income and aging F Pammolli, M Riccaboni, L Magazzini The European Journal of Health Economics 13, 623-634, 2012 | 151 | 2012 |
| Dynamic competition in pharmaceuticals: patent expiry, generic penetration, and industry structure L Magazzini, F Pammolli, M Riccaboni The European Journal of Health Economics, formerly: HEPAC 5, 175-182, 2004 | 122 | 2004 |
| Medical devices competitiveness and impact on public health expenditure F Pammolli, M Riccaboni, C Oglialoro, L Magazzini, G Baio, N Salerno | 121 | 2005 |
| Everything you always wanted to know about inventors (but never asked): Evidence from the PatVal-EU survey P Giuri, M Mariani, S Brusoni, G Crespi, D Francoz, A Gambardella, ... Centre for Economic Policy Research, 2006 | 102 | 2006 |
| Learning from failures or failing to learn? Lessons from pharmaceutical R&D L Magazzini, F Pammolli, M Riccaboni European Management Review 9 (1), 45-58, 2012 | 70 | 2012 |
| The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis F Pammolli, L Magazzini, L Orsenigo Revue d'économie industrielle 99 (1), 107-131, 2002 | 55 | 2002 |
| Patent disclosure and R&D competition in pharmaceuticals L Magazzini, F Pammolli, M Riccaboni, MA Rossi Economics of Innovation and New Technology 18 (5), 467-486, 2009 | 40 | 2009 |
| Learning from successes and failures in pharmaceutical R&D JY Chiou, L Magazzini, F Pammolli, M Riccaboni Journal of Evolutionary Economics 26, 271-290, 2016 | 23 | 2016 |
| Everything you always wanted to know about inventors (but never asked): evidence from the PatVal-EU Survey S Brusoni, G Crespi, D Francoz Centre for Economic Policy Research, 2006 | 22* | 2006 |
| Real Options and Incremental Search in Pharmaceutical R & D Project Portfolio Management L Magazzini, F Pammolli, M Riccaboni Creativity and Innovation Management 25 (2), 292-302, 2016 | 18 | 2016 |
| The value of failures in pharmaceutical R&D JY Chiou, L Magazzini, F Pammolli, M Riccaboni IMT Institute for Advanced Studies, 2012 | 14 | 2012 |
| Testing initial conditions in dynamic panel data models L Magazzini, G Calzolari Econometric Reviews 39 (2), 115-134, 2019 | 11 | 2019 |
| Simulation-based estimation of Tobit model with random effects G Calzolari, L Magazzini, F Mealli Econometric Studies: A Festschrift in Honour of Joachim Frohn 8, 349, 2001 | 11 | 2001 |
| R&D and market size: Who benefits from orphan drug legislation? S Gamba, L Magazzini, P Pertile Journal of Health Economics 80, 102522, 2021 | 10 | 2021 |
| Resale price maintenance: an empirical analysis of UK firms’ compliance E Giovannetti, L Magazzini The Economic Journal 123 (572), F582-F595, 2013 | 10 | 2013 |
| Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood G Calzolari, L Magazzini Empirical Economics 43, 145-152, 2012 | 9 | 2012 |
| Negative variance estimates in panel data models L Magazzini, G Calzolari University of Verona, 2010 | 9 | 2010 |
